Optimark MRI Contrast Agent NSF Warning Updated
The makers of Optimark, a gadolinium-based MRI contrasting agent, are changing the warning label to indicate that Optimark should not be used by patients with severe kidney problems. The label…
Tag Archives: Omniscan
-
-
Nephrogenic Systemic Fibrosis Warnings to be Reviewed Again by FDA
An FDA advisory committee is planning to review a decision by the agency to place the same warning on all gadolinium-based MRI contrast agents about the risk of nephrogenic systemic…
-
Nephrogenic Systemic Fibrosis Settlements Being Negotiated on Bayer Magnevist Lawsuits
According to U.S. District Judge Dan Polster, Bayer Healthcare has initiated settlement negotiations with a number of plaintiffs who have filed Nephrogenic Systemic Fibrosis lawsuits after receiving the gadolinium-based Magnevist…
